EL
Elicio Therapeutics, Inc. (ELTX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$1.87
+2.73%
Mkt Cap $59.49M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | — | — | — | -$0.47 | -$0.49 | -4.26% |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.62 | -$0.60 | +3.23% |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.69 | -$0.66 | +4.35% |
| Q2 2025 May 13, 2025 | — | — | — | -$0.67 | -$0.87 | -29.85% |
| Q1 2025 Mar 31, 2025 | — | $1.17M | — | -$0.94 | -$1.02 | -8.51% |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.81 | -$1.39 | -71.60% |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.96 | -$0.64 | +33.33% |
| Q2 2024 May 15, 2024 | — | — | — | -$1.09 | -$1.15 | -5.50% |
| Q1 2024 Feb 13, 2024 | — | — | — | -$0.78 | -$1.75 | -124.36% |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.80 | -$1.27 | -58.75% |
| Q3 2023 Aug 11, 2023 | $800.00K | — | — | -$5.70 | -$2.61 | +54.21% |
| Q2 2023 May 10, 2023 | $800.00K | — | — | -$0.54 | -$0.15 | +72.22% |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$2.15 | — |
| Q3 2022 Sep 30, 2022 | $625.00K | — | — | -$3.20 | -$2.27 | +29.16% |
| Q2 2022 Jun 30, 2022 | $1.35M | $653.00K | -51.63% | -$4.63 | -$2.37 | +48.94% |
| Q1 2022 Mar 31, 2022 | — | $1.65M | — | — | -$4.75 | — |
| Q4 2021 Dec 31, 2021 | — | $25.94M | — | — | $4.97 | — |
| Q3 2021 Sep 29, 2021 | — | $1.46M | — | — | -$5.26 | — |
| Q2 2021 Jun 30, 2021 | — | $540.00K | — | — | -$5.75 | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.47 | — |
| Q4 2020 Dec 31, 2020 | — | $459.00K | — | — | -$3.87 | — |
| Q3 2020 Sep 30, 2020 | — | $827.00K | — | — | -$2.37 | — |
| Q2 2020 Jun 30, 2020 | — | $729.00K | — | — | -$2.72 | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$0.44 | — |
| Q4 2019 Dec 31, 2019 | — | $696.00K | — | — | -$5.43 | — |